Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_assertion type Assertion NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_head.
- NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_assertion description "[We found that PON1 activity and concentration were significantly lower and CCL2 concentration higher in PAD patients compared to controls, that the combination of plasma CCL2 and PON1- related values, especially PON1 concentration differentiated, almost perfectly, controls from patients and that the expression of CCL2 and PON1 generally co-localized in the atherosclerotic lesion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_provenance.
- NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_assertion evidence source_evidence_literature NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_provenance.
- NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_assertion SIO_000772 21663591 NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_provenance.
- NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_assertion wasDerivedFrom befree-20150227 NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_provenance.
- NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_assertion wasGeneratedBy ECO_0000203 NP685100.RAQirS2g4iBKmu2OiPwlGl5dMXi6PuEyVvv4yrJBoptjA130_provenance.